These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
679 related articles for article (PubMed ID: 15308689)
1. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. Kang Z; Jänne OA; Palvimo JJ Mol Endocrinol; 2004 Nov; 18(11):2633-48. PubMed ID: 15308689 [TBL] [Abstract][Full Text] [Related]
2. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor. Yoon HG; Wong J Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395 [TBL] [Abstract][Full Text] [Related]
3. Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. Kang Z; Pirskanen A; Jänne OA; Palvimo JJ J Biol Chem; 2002 Dec; 277(50):48366-71. PubMed ID: 12376534 [TBL] [Abstract][Full Text] [Related]
4. Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR). Berrevoets CA; Umar A; Trapman J; Brinkmann AO Biochem J; 2004 May; 379(Pt 3):731-8. PubMed ID: 14744261 [TBL] [Abstract][Full Text] [Related]
5. Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells. Shi XB; Xue L; Zou JX; Gandour-Edwards R; Chen H; deVere White RW Prostate; 2008 Dec; 68(16):1816-26. PubMed ID: 18780293 [TBL] [Abstract][Full Text] [Related]
6. Dynamic methylation of histone H3 at lysine 4 in transcriptional regulation by the androgen receptor. Kim J; Jia L; Tilley WD; Coetzee GA Nucleic Acids Res; 2003 Dec; 31(23):6741-7. PubMed ID: 14627807 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens. Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455 [TBL] [Abstract][Full Text] [Related]
8. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors. Hodgson MC; Astapova I; Hollenberg AN; Balk SP Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755 [TBL] [Abstract][Full Text] [Related]
9. Dynamic nucleosome-depleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells. Andreu-Vieyra C; Lai J; Berman BP; Frenkel B; Jia L; Jones PA; Coetzee GA Mol Cell Biol; 2011 Dec; 31(23):4648-62. PubMed ID: 21969603 [TBL] [Abstract][Full Text] [Related]
11. Androgen receptor overexpression alters binding dynamics of the receptor to chromatin and chromatin structure. Urbanucci A; Marttila S; Jänne OA; Visakorpi T Prostate; 2012 Aug; 72(11):1223-32. PubMed ID: 22212979 [TBL] [Abstract][Full Text] [Related]
12. Androgen receptor amplification is reflected in the transcriptional responses of Vertebral-Cancer of the Prostate cells. Makkonen H; Kauhanen M; Jääskeläinen T; Palvimo JJ Mol Cell Endocrinol; 2011 Jan; 331(1):57-65. PubMed ID: 20728506 [TBL] [Abstract][Full Text] [Related]
13. Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes. Dai Y; Ngo D; Jacob J; Forman LW; Faller DV Carcinogenesis; 2008 Sep; 29(9):1725-33. PubMed ID: 18487222 [TBL] [Abstract][Full Text] [Related]
14. Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor. Masiello D; Cheng S; Bubley GJ; Lu ML; Balk SP J Biol Chem; 2002 Jul; 277(29):26321-6. PubMed ID: 12015321 [TBL] [Abstract][Full Text] [Related]
15. Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers. Makkonen H; Kauhanen M; Paakinaho V; Jääskeläinen T; Palvimo JJ Nucleic Acids Res; 2009 Jul; 37(12):4135-48. PubMed ID: 19433513 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of HER-2/neu kinase impairs androgen receptor recruitment to the androgen responsive enhancer. Liu Y; Majumder S; McCall W; Sartor CI; Mohler JL; Gregory CW; Earp HS; Whang YE Cancer Res; 2005 Apr; 65(8):3404-9. PubMed ID: 15833875 [TBL] [Abstract][Full Text] [Related]
17. Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms. Jia L; Kim J; Shen H; Clark PE; Tilley WD; Coetzee GA Mol Cancer Res; 2003 Mar; 1(5):385-92. PubMed ID: 12651911 [TBL] [Abstract][Full Text] [Related]
18. A novel androgen receptor-binding element modulates Cdc6 transcription in prostate cancer cells during cell-cycle progression. Jin F; Fondell JD Nucleic Acids Res; 2009 Aug; 37(14):4826-38. PubMed ID: 19520769 [TBL] [Abstract][Full Text] [Related]
19. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes. Axlund SD; Lambert JR; Nordeen SK Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772 [TBL] [Abstract][Full Text] [Related]